Prenetics Global Limited reported $92M of revenue over the trailing twelve months, +480% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $92M (to FY2025). Net income: −$38M, trailing twelve months to FY2025. Free cash flow: −$22M, trailing twelve months to FY2025. Operating margin: −48%, trailing twelve months to FY2025.

PREPrenetics Global Limited

Healthcare

$17.42+6.8% 1Y

$17.42

$11.7952 weeks$26.30

PRE as reported

Prenetics Global Limited reported $92M of revenue over the trailing twelve months, +480% on the year before. 9 reported series are charted on this page, each one as filed.

$92M

Revenue, trailing twelve months · to FY2025 · +480% against the twelve months before

Net income: −$38M
Net income · −19% year on year · trailing twelve months to FY2025
Free cash flow: −$22M
Free cash flow · −26% year on year · trailing twelve months to FY2025
Operating margin: −48%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for PRE, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$92M	+480%	FY2025
Net income	−$38M	−19%	FY2025
EPS	−$2.68	−28%	FY2025
Gross margin	53%	n/a	FY2025
Operating margin	−48%	n/a	FY2025
Net margin	−41%	n/a	FY2025
ROE	−24%	n/a	FY2025
ROA	−18%	n/a	FY2025
Free cash flow	−$22M	−26%	FY2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.